The Role of HGFIN in Breast Cancer
Author Information
Author(s): Rebecca L Metz, Prem S Patel, Meera Hameed, Margaret Bryan, Pranela Rameshwar
Primary Institution: UMDNJ-New Jersey Medical School
Hypothesis
HGFIN may act as a tumor suppressor in breast cancer by regulating cell growth and migration.
Conclusion
HGFIN expression is reduced in malignant breast cancer cells, suggesting it may play a role in tumor suppression.
Supporting Evidence
- HGFIN expression is significantly higher in non-tumorigenic breast cells compared to malignant cells.
- Knockout of HGFIN in non-tumorigenic cells leads to increased cell growth and migration.
- Ectopic expression of HGFIN in breast cancer cells reduces their growth and migration.
Takeaway
HGFIN is a protein that helps keep breast cells healthy, and when it's missing, the cells can become cancerous and grow uncontrollably.
Methodology
The study used siRNA to knock out HGFIN in non-tumorigenic breast cells and ectopically expressed HGFIN in breast cancer cells, along with in situ hybridization and reporter gene assays.
Potential Biases
Potential bias in patient selection and hormonal status not being controlled.
Limitations
The study primarily focused on one variant of HGFIN and did not explore the effects of other variants.
Participant Demographics
Patients diagnosed with infiltrating ductal carcinomas, with varying hormone receptor statuses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website